Medicare Enrolled

Dr. Arthur Mourtzinos, M.D.

Urology Physician · Burlington, MA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
41 MALL RD, Burlington, MA 01805
7817445481
In practice since 2006 (20 years)
NPI: 1649238577 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Mourtzinos from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mourtzinos? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Mourtzinos

Dr. Arthur Mourtzinos is an urology physician in Burlington, MA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Mourtzinos performed 2,372 Medicare services across 2,183 unique beneficiaries.

Between the years covered by Open Payments, Dr. Mourtzinos received a total of $41,625 from 21 pharmaceutical and/or device companies across 208 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Mourtzinos is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 39% volume in MA $41,625 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,372
Medicare services
Top 39% in MA for urology physician
2,183
Unique beneficiaries
$78
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~119 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
778 $77 $345
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
278 $105 $493
Cystourethroscopy
A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract.
153 $57 $708
Non-needle muscle activity measurement of bladder and bowel openings
This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles.
131 $16 $321
Complex urodynamic pressure flow study
A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning.
130 $87 $453
Abdominal device insertion with pressure and urine flow study
A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate.
130 $33 $173
Radiologist review of bladder and urethra images with contrast
A radiologist reviews medical images of the urinary bladder and urethra taken with contrast dye, including images captured after the patient has urinated.
125 $13 $72
Voiding cystourethrogram
An imaging procedure that uses X-rays to visualize the bladder and urethra while urine is being passed.
124 $18 $377
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
122 $109 $488
Cystoscopy with chemical ablation of bladder
A procedure where a camera is used to examine the bladder and a chemical agent is applied to destroy abnormal tissue.
63 $137 $856
New patient office visit, complex (60-74 min) 62 $142 $630
Electronic assessment of bladder emptying
A test that uses electronic monitoring to evaluate how well the bladder empties urine.
52 $4 $104
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
47 $54 $234
Hospital follow-up visit, low complexity
Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service.
44 $43 $136
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
37 $113 $401
Waterjet prostate destruction via urethra
A procedure that uses a high-pressure water jet to destroy prostate tissue, accessed through the urethra.
19 $655 $2,393
Sacral nerve stimulator electrode insertion
A procedure to place an electrode array in the sacral area to deliver electrical stimulation to the nerves.
19 $283 $4,186
Electronic analysis of implanted neurostimulator
Electronic evaluation of an implanted brain, spinal cord, or peripheral nerve stimulator device.
18 $15 $191
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
18 $69 $334
Insertion of inflatable urethral or bladder neck sphincter
A surgical procedure to place an inflatable device that helps control urine flow by compressing the urethra or bladder neck.
11 $667 $3,093
Insertion of peripheral or gastric neurostimulator generator
A surgical procedure to implant the pulse generator device for a neurostimulator system. The generator is placed under the skin to deliver electrical impulses to nerves or the stomach.
11 $84 $540
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
2.7% high complexity
0.0% medium
97.3% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$41,625
Total received (2018-2024)
Avg $5,946/year across 7 years
Top 8% in MA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
21
Companies
208
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$37,154 (89.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,471 (10.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$7,301
2023
$11,284
2022
$8,176
2021
$4,912
2020
$1,827
2019
$5,447
2018
$2,677

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$6,571
Medtronic, Inc.
$273
Ambu Inc.
$140
C. R. Bard, Inc. & Subsidiaries
$108
ABBVIE INC.
$103
Ferring Pharmaceuticals Inc.
$78
Sumitomo Pharma America, Inc.
$27
Top 3 companies account for 95.7% of 2024 payments
All-time payments by company (2018-2024) ›
Medtronic, Inc.
$22,776
Medtronic USA, Inc.
$7,919
Boston Scientific Corporation
$6,845
NeoTract Inc.
$967
PROCEPT BioRobotics Corporation
$794
Astellas Pharma US Inc
$606
ABBVIE INC.
$319
DENTSPLY IH Inc.
$266
Ambu Inc.
$227
Rochester Medical Corporation
$176
C. R. Bard, Inc. & Subsidiaries
$165
UROVANT SCIENCES INC
$147
Allergan Inc.
$118
Teleflex LLC
$93
Ferring Pharmaceuticals Inc.
$78
Sumitomo Pharma America, Inc.
$27
Olympus America Inc.
$27
Allergan, Inc.
$25
Caldera Medical, Inc
$19
KARL STORZ Endoscopy-America
$17
Axonics, Inc.
$15
Top 3 companies account for 90.2% of all-time payments
Associated products mentioned in payments ›
24FR BIPLR COAG ELECTRDE · ADSTILADRIN · AMS 700 · AMS 800 Artificial Urinary Sphincter · AQUABEAM ROBOTIC SYSTEM · AquaBeam Robotic System · BOTOX · BOTOX - UROLOGY · BOTOX COSMETIC · Bard Urinary Drainage Bag · Bulkamid · Desara · GEMTESA · General - Erectile Dysfunction · INTERSTIM · INTERSTIM ICON · LoFric · MAGIC3 · MYRBETRIQ · Myrbetriq · PKG/6 · STERILE · UROLIFT · UroLift · UroLift System · XTANDI · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (89%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in urology physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 8% for urology physician in MA.

Looking for an urology physician in Burlington?
Compare urology physicians in the Burlington area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Mourtzinos is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 8% of MA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Mourtzinos experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Mourtzinos performed 778 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mourtzinos receive payments from pharmaceutical companies?
Yes. Dr. Mourtzinos received a total of $41,625 from 21 companies across 208 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mourtzinos's costs compare to other urology physicians in Burlington?
Dr. Mourtzinos's average Medicare payment per service is $78. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mourtzinos) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →